NCT03253679 2023-10-17AZD1775 in Treating Patients With Advanced Refractory Solid Tumors With CCNE1 AmplificationNational Cancer Institute (NCI)Phase 2 Completed31 enrolled 13 charts
NCT01827384 2023-09-29MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene VariationsNational Cancer Institute (NCI)Phase 2 Completed208 enrolled 27 charts